Dr. Derek L Stirewalt graduated from Davidson College in 1988 and obtained his MD at the University of North Carolina at Chapel Hill in 1992. From 1996 to 1999, he served as an Oncology Fellow at the University of Washington. He is currently a Professor in the Translational Science and Therapeutics Division at the Fred Hutchinson Cancer Center and Associate Professor in the Hematology and Oncology Division at the University of Washington. In addition, he is the Director of the Fred Hutch/UW Hematopoietic Diseases Repository. His clinical expertise lies in evaluating and treating patients with hematopoietic malignancies, with a particular interest in those patients with leukemia. His research goals are to identify novel biomarkers for hematopoietic malignancies and to understand how these biomarkers may function to promote the development of diseases.
Dr. Derek L Stirewalt graduated from Davidson College in 1988 and obtained his MD at the University of North Carolina at Chapel Hill in 1992. From 1996 to 1999, he served as an Oncology Fellow at the University of Washington. He is currently a Professor in the Translational Science and Therapeutics Division at the Fred Hutchinson Cancer Center and Associate Professor in the Hematology and Oncology Division at the University of Washington. In addition, he is the Director of the Fred Hutch/UW Hematopoietic Diseases Repository. His clinical expertise lies in evaluating and treating patients with hematopoietic malignancies, with a particular interest in those patients with leukemia. His research goals are to identify novel biomarkers for hematopoietic malignancies and to understand how these biomarkers may function to promote the development of diseases.